Crispr Stock Volume Indicators Chaikin AD Oscillator

CRSP
 Stock
  

USD 48.99  1.51  2.99%   

Crispr Therapeutics volume indicators tool provides the execution environment for running the Chaikin AD Oscillator indicator and other technical functions against Crispr Therapeutics. Crispr Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of volume indicators indicators. As with most other technical indicators, the Chaikin AD Oscillator indicator function is designed to identify and follow existing trends. Crispr Therapeutics volume indicators are based on Chaikin accumulation (buying pressure) and distribution (selling pressure) factors to determine the likely sustainability of a given price move. Please specify Fast Period and Slow Period to execute this module.

Indicator
Fast Period
Slow Period
Execute Indicator
The output start index for this execution was nine with a total number of output elements of fifty-two. The Accumulation/Distribution Oscillator was developed by Marc Chaikin. It is a moving average oscillator based on the Accumulation/Distribution indicator. The Chaikin Oscillator is created by subtracting Crispr Therapeutics 10-period exponential moving average of the Accumulation/Distribution Line from a 3-period exponential moving average of the Accumulation/Distribution Line.
.

Crispr Therapeutics Technical Analysis Modules

Most technical analysis of Crispr Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Crispr from various momentum indicators to cycle indicators. When you analyze Crispr charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Crispr Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Crispr Therapeutics AG. We use our internally-developed statistical techniques to arrive at the intrinsic value of Crispr Therapeutics AG based on widely used predictive technical indicators. In general, we focus on analyzing Crispr Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Crispr Therapeutics's daily price indicators and compare them against related drivers, such as volume indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Crispr Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Crispr Therapeutics, we also check how macroeconomic factors affect Crispr Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Crispr Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Crispr Therapeutics in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
43.6947.5051.31
Details
Intrinsic
Valuation
LowReal ValueHigh
44.0974.9678.77
Details
Naive
Forecast
LowNext ValueHigh
40.7844.5948.40
Details
16 Analysts
Consensus
LowTarget PriceHigh
100.00160.69220.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Crispr Therapeutics. Your research has to be compared to or analyzed against Crispr Therapeutics' peers to derive any actionable benefits. When done correctly, Crispr Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Crispr Therapeutics.

Be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Generate Optimal Portfolios

Align your risk and return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Continue to Trending Equities. You can also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for analysis

When running Crispr Therapeutics price analysis, check to measure Crispr Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crispr Therapeutics is operating at the current time. Most of Crispr Therapeutics' value examination focuses on studying past and present price action to predict the probability of Crispr Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Crispr Therapeutics' price. Additionally, you may evaluate how the addition of Crispr Therapeutics to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Is Crispr Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Crispr Therapeutics. If investors know Crispr will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Crispr Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
3.9 B
Quarterly Revenue Growth YOY
(0.89) 
Return On Assets
(0.17) 
Return On Equity
(0.30) 
The market value of Crispr Therapeutics is measured differently than its book value, which is the value of Crispr that is recorded on the company's balance sheet. Investors also form their own opinion of Crispr Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Crispr Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Crispr Therapeutics' market value can be influenced by many factors that don't directly affect Crispr Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Crispr Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Crispr Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Crispr Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.